Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elske Quak

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Diagnostics (Basel, Switzerland)|May 13, 2023
Deep Learning Denoising Improves and Homogenizes Patient [<sup>18</sup>F]FDG PET Image Quality in Digital PET/CTKathleen Weyts, Elske Quak, Idlir Licaj, et al.
European Journal of Endocrinology|May 29, 2014
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burdenRenaud Ciappuccini, Juliette Hardouin, Natacha Heutte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 20, 2022
Artificial intelligence-based PET denoising could allow a two-fold reduction in [<sup>18</sup>F]FDG PET acquisition time in digital PET/CTKathleen Weyts, Charline Lasnon, Renaud Ciappuccini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2024
Cost-effectiveness of one-stop-shop [<sup>18</sup>F]Fluorocholine PET/CT to localise parathyroid adenomas in patients suffering from primary hyperparathyroidismSietse van Mossel, Sopany Saing, Natasha Appelman-Dijkstra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2026
First-line [<sup>18</sup>F]F-choline PET/CT in primary hyperparathyroidism: a cost-effectiveness study from the diagnostic randomized APACH2 trialElske Quak, Audrey Lasne-Cardon, Marie Cavarec, et al.
Expert Review of Anticancer Therapy|February 24, 2011
Clinical applications of positron emission tomography in sarcoma managementElske Quak, Addy C M van de Luijtgaarden, Lioe-Fee de Geus-Oei, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 13, 2010
[Diarrhoea and fever in chemotherapy patients due to listeriosis]Elske Quak, Hanneke W M van Laarhoven, Henk Bos, et al.
The Journal of Clinical Endocrinology and Metabolism|October 11, 2014
Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancerStéphane Bardet, Renaud Ciappuccini, Elske Quak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patientsElske Quak, Pierre-Yves Le Roux, Michael S Hofman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2017
F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 studyElske Quak, David Blanchard, Benjamin Houdu, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Diagnostics (Basel, Switzerland)|May 13, 2023
Deep Learning Denoising Improves and Homogenizes Patient [<sup>18</sup>F]FDG PET Image Quality in Digital PET/CTKathleen Weyts, Elske Quak, Idlir Licaj, et al.
European Journal of Endocrinology|May 29, 2014
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burdenRenaud Ciappuccini, Juliette Hardouin, Natacha Heutte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 20, 2022
Artificial intelligence-based PET denoising could allow a two-fold reduction in [<sup>18</sup>F]FDG PET acquisition time in digital PET/CTKathleen Weyts, Charline Lasnon, Renaud Ciappuccini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2024
Cost-effectiveness of one-stop-shop [<sup>18</sup>F]Fluorocholine PET/CT to localise parathyroid adenomas in patients suffering from primary hyperparathyroidismSietse van Mossel, Sopany Saing, Natasha Appelman-Dijkstra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2026
First-line [<sup>18</sup>F]F-choline PET/CT in primary hyperparathyroidism: a cost-effectiveness study from the diagnostic randomized APACH2 trialElske Quak, Audrey Lasne-Cardon, Marie Cavarec, et al.
Expert Review of Anticancer Therapy|February 24, 2011
Clinical applications of positron emission tomography in sarcoma managementElske Quak, Addy C M van de Luijtgaarden, Lioe-Fee de Geus-Oei, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 13, 2010
[Diarrhoea and fever in chemotherapy patients due to listeriosis]Elske Quak, Hanneke W M van Laarhoven, Henk Bos, et al.
The Journal of Clinical Endocrinology and Metabolism|October 11, 2014
Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancerStéphane Bardet, Renaud Ciappuccini, Elske Quak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patientsElske Quak, Pierre-Yves Le Roux, Michael S Hofman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2017
F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 studyElske Quak, David Blanchard, Benjamin Houdu, et al.
Pageof 4